Lipid News

The many layers of cholesterol regulation

Arun Radhakrishnan
By Arun Radhakrishnan
Oct. 1, 2017

Cholesterol levels in the membranes of animal cells are regulated carefully to remain within narrow limits. Regulation is carried out by a network of proteins that resides in the endoplasmic reticulum, or ER, and controls the two pathways by which cells obtain cholesterol: synthesis and uptake from circulating lipoproteins. The key proteins of this network include a cholesterol sensor and a transcription factor. The sensor is Scap, a polytopic ER membrane protein that binds membrane cholesterol. The transcription factor is a domain of another ER membrane protein called sterol regulatory element-binding protein, or SREBP.

Cholesterol accessibility at the surfaces of membranes rises sharply when its concentration exceeds a threshold, and plays a role in regulating the total cellular level and intracellular distribution of cholesterol. courtesy of Anna Sokolov and Arun Radhakrishnan​

When ER cholesterol is low, Scap initiates a series of molecular events that eventually release SREBP’s transcription factor domain into the cytosol so it can travel to the nucleus to upregulate genes for cholesterol synthesis and uptake. When ER cholesterol rises above a threshold, Scap binds cholesterol and undergoes a conformation change that blocks the processing of SREBPs. Thus, Scap spearheads a feedback mechanism that ensures rapid adjustments to changes in cellular cholesterol levels to ensure cholesterol homeostasis.

However, the cellular distribution of cholesterol poses a significant challenge to this feedback mechanism. Seventy to 90 percent of the cell’s cholesterol is located in the plasma membrane, or PM, whereas Scap is in the ER, which contains only about 1 percent of the cell’s cholesterol. If Scap is to execute its sensing function, the cholesterol-poor ER must be in constant communication with the cholesterol-rich PM so it can be notified promptly of changes in cholesterol levels. Without such a link, Scap would be blind to changes in cellular cholesterol. Indeed, disrupting this link through the use of a toxin that sequesters cholesterol in the PM results in a lowering of ER cholesterol even though PM cholesterol is unchanged. In response to this artificial induction, Scap activates SREBPs even though cellular cholesterol has not been depleted.

How are cholesterol levels in ER linked to those in PM? This process requires mechanisms to transport hydrophobic cholesterol across the aqueous cytosol and mechanisms to regulate these transport pathways. Cholesterol transport likely involves a combination of vesicular, nonvesicular and membrane contact site-mediated pathways, and remains poorly understood. We know a little more about how this transport may be regulated. Recent work has used soluble cholesterol-binding toxins to assay the exposure of cholesterol at the surface of purified PMs. These studies revealed that PM cholesterol was sequestered in the membrane bilayer and inaccessible to toxins until it exceeded a threshold concentration of about 35 mole percent of total PM lipids. Above this sharp threshold, PM cholesterol was accessible to bind to toxins. Sharp changes that have been observed for the exposure of PM cholesterol to the enzyme cholesterol oxidase may occur at similar thresholds.

It is tempting to speculate that intracellular cholesterol transport pathways are also sensitive to a sharp change in accessibility of cholesterol on the cytoplasmic leaflet of the PM, allowing for transport to ER to occur only after the PM’s cholesterol needs have been satisfied. How subthreshold levels of cholesterol are sequestered in the PM to prevent interactions with the intracellular transport machinery remains a mystery. We have learned a lot, but there are many more layers of cholesterol regulation yet to be revealed.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Arun Radhakrishnan
Arun Radhakrishnan

Arun Radhakrishnan is an assistant professor in the Department of Molecular Genetics, University of Texas Southwestern Medical Center.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Engineering the future with synthetic biology
ASBMB Annual Meeting

Engineering the future with synthetic biology

March 31, 2025

Learn about the ASBMB 2025 symposium on synthetic biology, featuring applications to better human and environmental health.

Scientists find bacterial ‘Achilles’ heel’ to combat antibiotic resistance
Webinar

Scientists find bacterial ‘Achilles’ heel’ to combat antibiotic resistance

March 28, 2025

Alejandro Vila, an ASBMB Breakthroughs speaker, discussed his work on metallo-β-lactamase enzymes and their dependence on zinc.

Host vs. pathogen and the molecular arms race
ASBMB Annual Meeting

Host vs. pathogen and the molecular arms race

March 28, 2025

Learn about the ASBMB 2025 symposium on host–pathogen interactions, to be held Sunday, April 13 at 1:50 p.m.

Richard Silverman to speak at ASBMB 2025
ASBMB Annual Meeting

Richard Silverman to speak at ASBMB 2025

March 27, 2025

Richard Silverman and Melissa Moore are the featured speakers at the ASBMB annual meeting to be held April 12-15 in Chicago.

From the Journals: JBC
Journal News

From the Journals: JBC

March 25, 2025

How cells recover from stress. Cancer cells need cysteine to proliferate. Method to make small membrane proteins. Read about papers on these topics recently published in the Journal of Biological Chemistry.

ASBMB names 2025 JBC/Tabor Award winners
Award

ASBMB names 2025 JBC/Tabor Award winners

March 24, 2025

The six awardees are first authors of outstanding papers published in 2024 in the Journal of Biological Chemistry.